Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines. The deal could be ...

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...

Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered. Bristol Myers Squibb ...

Abstract: Recently, a severe danger has evolved regarding the explosion of Electric Vehicle (EV) batteries due to their thermal issues. A proficient system is employed for managing the operations of ...

Abstract: Battery monitoring is vital for most electric vehicles (EVs), because the safety, operation, and even the life of the passenger depends on the battery system. This attribute is exactly the ...

This project is a rewrite of [low-cost-bms][1] for a new hardware platform based on the cheap and powerful STM32. A BMS, or battery management system, is an essential part of any multi battery Lithium ...

Herramienta avanzada de diagnóstico para baterías Makita LXT de 18V (BL18) y 14.4V (BL14) basada en ESP32.